Medicine and Dentistry
Adjuvant Chemotherapy
100%
Aminophylline
33%
Bladder Cancer
100%
Cisplatin
100%
Contraindication
33%
Cyclophosphamide
100%
Cystectomy
66%
Disease Free Survival
100%
Diseases
33%
Doxorubicin
100%
Lymph Duct
66%
Neoplasm
66%
Nodal Metastasis
66%
Pelvic Viscera
33%
Pelvis
33%
Primary Tumor
66%
Recurrent Disease
33%
Keyphrases
Adjuvant Chemotherapy
42%
Adria
14%
Adriamycin
14%
Bladder Cancer
100%
Bristol
14%
Chemotherapy
100%
Cisplatin
14%
Cisplatin-based Chemotherapy
100%
Columbus
14%
Cyclophosphamide
100%
Cystectomy
28%
Cytoxan
14%
Direct Invasion
14%
Disease-free
14%
Disease-free Survival
14%
Doxorubicin
14%
Doxorubicin Treatments
100%
High Risk
42%
Long-term Disease-free Survival
28%
Lymphovascular Invasion
14%
Medical Contraindications
14%
Nodal Metastasis
28%
Pathological Findings
42%
Pelvic Peritoneum
14%
Poor Prognostic
14%
Primary Tumor
28%
Prognostic Features
14%
Risk for Relapse
28%
Survival Benefit
14%
Tumor Invasion
14%
Tumor Lymphatics
14%
Nursing and Health Professions
Adjuvant Chemotherapy
100%
Aminophylline
33%
Bladder Cancer
100%
Cisplatin
100%
Contraindication
33%
Cyclophosphamide
100%
Cystectomy
66%
Disease Free Survival
100%
Diseases
33%
Doxil
100%
Neoplasm
66%
Primary Tumor
66%
Recurrent Disease
33%